Enzolytics Inc (ENZC)
0.0035
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Enzolytics 1 Year Total Returns (Daily): -95.51% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -95.51% |
May 02, 2024 | -94.93% |
May 01, 2024 | -92.97% |
April 30, 2024 | -92.03% |
April 29, 2024 | -91.77% |
April 26, 2024 | -89.96% |
April 25, 2024 | -91.49% |
April 24, 2024 | -91.65% |
April 23, 2024 | -91.64% |
April 22, 2024 | -94.20% |
April 19, 2024 | -90.26% |
April 18, 2024 | -90.10% |
April 17, 2024 | -89.60% |
April 16, 2024 | -90.54% |
April 15, 2024 | -88.04% |
April 12, 2024 | -83.17% |
April 11, 2024 | -81.89% |
April 10, 2024 | -82.32% |
April 09, 2024 | -82.25% |
April 08, 2024 | -82.86% |
April 05, 2024 | -82.02% |
April 04, 2024 | -82.32% |
April 03, 2024 | -81.85% |
April 02, 2024 | -80.17% |
April 01, 2024 | -78.94% |
Date | Value |
---|---|
March 28, 2024 | -76.89% |
March 27, 2024 | -78.28% |
March 26, 2024 | -81.26% |
March 25, 2024 | -76.69% |
March 22, 2024 | -71.82% |
March 21, 2024 | -71.43% |
March 20, 2024 | -75.61% |
March 19, 2024 | -77.83% |
March 18, 2024 | -74.63% |
March 15, 2024 | -71.45% |
March 14, 2024 | -70.93% |
March 13, 2024 | -71.97% |
March 12, 2024 | -71.19% |
March 11, 2024 | -69.47% |
March 08, 2024 | -70.66% |
March 07, 2024 | -69.38% |
March 06, 2024 | -67.43% |
March 05, 2024 | -67.81% |
March 04, 2024 | -66.19% |
March 01, 2024 | -66.28% |
February 29, 2024 | -66.29% |
February 28, 2024 | -63.09% |
February 27, 2024 | -68.26% |
February 26, 2024 | -66.12% |
February 23, 2024 | -70.97% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-97.14%
Minimum
Jan 10 2020
324.9K%
Maximum
Feb 24 2021
10.23K%
Average
-49.84%
Median
Jan 04 2024
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -90.79% |
Palatin Technologies Inc | -3.65% |
iBio Inc | -90.87% |
Theriva Biologics Inc | -37.06% |
Oragenics Inc | -59.32% |